Cardiovascular

ACOG’s Pregnancy and Heart Disease 20XX Practice Bulletin includes a level C recommendation that: “All women should be assessed for cardiovascular disease in the antepartum and postpartum periods using the California Improving Health Care Response to Cardiovascular Disease in Pregnancy and Postpartum toolkit algorithm.” ACOG recognizes the Standing Committee’s concerns related to the availability of the evidence, and encourages reconsideration of the measure as soon as additional evidence is available. 

2558 Hospital 30-day, all-cause, risk-standardized mortality rate (RSMR) following coronary artery bypass graft (CABG) surgery

The American Medical Association (AMA) continues to have concerns with the low minimum measure score reliability result, the lack of adequate testing and adjustment for social risk factors, and the relatively limited amount of variation demonstrating such small differences in performance scores. We believe that these concerns must be addressed before endorsement is continued. 

3716 CVD Risk Assessment Measure – Proportion of Pregnant/Postpartum Patients That Receive CVD Risk Assessment With a Standardized Tool 

The American Medication Association (AMA) agrees with the Standing Committee’s concerns around the inadequacy of the evidence used to support the measure. We support the current recommendation to not endorse this measure. 

3735 CVD Risk Follow-up Measure - Proportion of patients with a positive CVD risk assessment who receive follow-up care

The American Medication Association (AMA) agrees with the Standing Committee’s concerns around the inadequacy of the evidence used to support the measure. We support the current recommendation to not endorse this measure.